Healthcare entity
Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Cibus Inc, the most common co-covered peer. Each story carries 2 original sources on average, compared with 2.5 for the broader beat in this window.
Last mentioned: Mar 18, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Cibus Inc, the most common co-covered peer. Each story carries 2 original sources on average, compared with 2.5 for the broader beat in this window. At 5, the average consequence score sits below the same-window beat average of 5.8. We currently track 1 Healthcare story that mention Haduvio, all published on March 18, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 24 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Haduvio. Shared-story counts are live from our verified record — not editorial picks.
Q4 Earnings Call
Management details strategic advances and future clinical roadmap.
Data Readout
Anticipated Phase 2b/3 data for Haduvio in chronic cough indications.
Fiscal Year End
Trevi concludes 2025 with key clinical milestones met for IPF chronic cough.
Q4 Strategic Pivot
Trevi refocuses resources on Haduvio's late-stage respiratory trials.
Trevi Therapeutics reported significant strategic progress in its Q4 2025 earnings, focusing on the clinical development of Haduvio for chronic cough in IPF. While the company achieves key R&D milestones, the broader biotech sector continues to navigate a complex financial landscape characterized by high capital costs and strategic realignments.
Source: finance.yahoo.com · finance.yahoo.com
Haduvio is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
